In in vitro studies, the over‐expression of TF and PAR‐2 in a CRC cell line led to increased proliferation and motility,11 possibly via PKCα and ERK1/2 signalling pathways.12, 13. The gene discussed is TF; the disease is colorectal carcinoma.